Metraipolis › archive › dc_f8cb9dc42e5d

Safety of a Tailored Gadolinium-Based Contrast Agent Protocol Considering Excretion Pathways in Patients with Renal Impairment — Europe PMC PMID:41681769

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41681769
DOI
10.3390/diagnostics16030451
License (as archived)
solo-consultazione
Archived
2026-11-06T08:56:46.895Z
SHA-256 of the archived text
e8cfb4e898bd1395074d2498f3e20f63062baeb8bcfa52da414e57de5458057d
Stable URL of this page
https://metraipolis.com/documento/dc_f8cb9dc42e5d

How to cite

Safety of a Tailored Gadolinium-Based Contrast Agent Protocol Considering Excretion Pathways in Patients with Renal Impairment — Europe PMC PMID:41681769 — Europe PMC (en), https://europepmc.org/article/MED/41681769 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f8cb9dc42e5d (Metraipolis archive dc_f8cb9dc42e5d, sha256 e8cfb4e898bd1395074d2498f3e20f63062baeb8bcfa52da414e57de5458057d)
BibTeX
@misc{dcf8cb9dc42e5d,
  title = {Safety of a Tailored Gadolinium-Based Contrast Agent Protocol Considering Excretion Pathways in Patients with Renal Impairment — Europe PMC PMID:41681769},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41681769},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f8cb9dc42e5d; sha256 e8cfb4e898bd1395074d2498f3e20f63062baeb8bcfa52da414e57de5458057d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41681769. Agents can read the archived copy with the MCP tool read_document.